Diagnosis of viral infections using myxovirus resistance protein a (MxA)

Pediatrics

Volumn 135, Issue 4, 2015, Pages e985-e993

  Engelmann, Ilka ^a   Dubos, François ^a   Lobert, Pierre Emmanuel ^a   Houssin, Claire ^a   Degas, Vanessa ^a   Sardet, Anne ^b   Decoster, Anne ^c   Dewilde, Anny ^a   Martinot, Alain ^a   Hober, Didier ^a  

^a UNIV LILLE   (France)

^b Centre Hospitalier de LENS   (France)

^c Centre Hospitalier Saint Philibert GHICL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MYXOVIRUS RESISTANCE PROTEIN A; MYXOVIRUS RESISTANCE PROTEIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BRONCHIOLITIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FEVER; GASTROENTERITIS; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTICENTER STUDY; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PYELONEPHRITIS; RASH; RECEIVER OPERATING CHARACTERISTIC; ROTAVIRUS; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION; VIRUS VIRULENCE; BACTERIAL INFECTIONS; BLOOD; DIFFERENTIAL DIAGNOSIS; EMERGENCY HEALTH SERVICE; FRANCE; NEWBORN; PREDICTIVE VALUE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; ROTAVIRUS INFECTIONS; VIRUS DISEASES;

ADOLESCENT; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYXOVIRUS RESISTANCE PROTEINS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; ROTAVIRUS INFECTIONS; VIRUS DISEASES;

EID: 84927775366     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1946     Document Type: Article

References (27)

1. Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol. 2000;81(pt 10):2341-2364
2. Roers A, Hochkeppel HK, Horisberger MA, Hovanessian A, Haller O. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis. 1994;169(4):807-813
3. Haller O, Kochs G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res. 2011;31(1):79-87
4. Lindenmann J. Resistance of mice to mouse-adapted influenza A virus. Virology. 1962;16:203-204
5. Chieux V, Hober D, Chehadeh W, et al. MxA protein in capillary blood of children with viral infections. J Med Virol. 1999;59(4):547-551
6. Nakabayashi M, Adachi Y, Itazawa T, et al. MxA-based recognition of viral illness in febrile children by a whole blood assay. Pediatr Res. 2006;60(6):770-774
7. Yoshimasu T, Manabe A, Ebihara Y, et al. MxA expression in patients with viral infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 2003;32(3):313-316
8. Koskenvuo MM, Halminen M, Blomqvist M, et al. Expression of MxA protein in blood lymphocytes of children receiving anticancer chemotherapy. Pediatr Hematol Oncol. 2006;23(8):649-660
9. Chieux V, Hober D, Harvey J, et al. The MxA protein levels in whole blood lysates of patients with various viral infections. J Virol Methods. 1998;70(2):183-191
10. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8
11. Chieux V, Chehadeh W, Harvey J, Haller O, Wattré P, Hober D. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology. 2001;283(1):84-92
12. Verstrepen WA, Kuhn S, Kockx MM, Van De Vyvere ME, Mertens AH. Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J Clin Microbiol. 2001;39(11):4093-4096
13. Towbin H, Schmitz A, Jakschies D, Von Wussow P, Horisberger MA. A whole blood immunoassay for the interferoninducible human Mx protein. J Interferon Res. 1992;12(2):67-74
14. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-217
15. Dubos F, Korczowski B, Aygun DA, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med. 2008;162(12):1157-1163
16. Dubos F, Moulin F, Gajdos V, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr. 2006;149(1):72-76
17. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107
18. Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. 1997;24(6):1240-1242
19. Kawamura M, Kusano A, Furuya A, et al. New sandwich-type enzyme-linked immunosorbent assay for human MxA protein in a whole blood using monoclonal antibodies against GTP-binding domain for recognition of viral infection. J Clin Lab Anal. 2012;26(3):174-183
20. Forster J, Schweizer M, Schumacher RF, Kaufmehl K, Lob S. MxA protein in infants and children with respiratory tract infection. Acta Paediatr. 1996;85(2):163-167
21. Peng XM, Lei RX, Gu L, Ma HH, Xie QF, Gao ZL. Influences of MxA gene-88 G/T and IFN-gamma +874 A/T on the natural history of hepatitis B virus infection in an endemic area. Int J Immunogenet. 2007;34(5):341-346
22. Kong XF, Zhang XX, Gong QM, et al. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment. J Interferon Cytokine Res. 2007;27(9):809-818
23. Knapp S, Yee LJ, Frodsham AJ, et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 2003;4(6):411-419
24. Cheng JC, Yeh YJ, Huang YH, et al. Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C. J Viral Hepat. 2012;19(2):e154-e162
25. Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309(3):275-282
26. Grijalva CG, Griffin MR. Unveiling the burden of influenza-associated pneumococcal pneumonia. J Infect Dis. 2012;205(3):355-357
27. Ghidini C, Zanotti C, Boccacci S, Lanfranchi A, Caimi L, Imberti L. MxA RNA quantification in febrile patients who underwent hematopoietic cell transplantation for primary immunodeficiency. Diagn Mol Pathol. 2011;20(2):111-116